US Stock MarketDetailed Quotes

CervoMed (CRVO)

Watchlist
  • 3.710
  • +0.020+0.54%
Close May 1 16:00 ET
  • 3.710
  • 0.0000.00%
Post 20:01 ET
34.35MMarket Cap-1.24P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CervoMed (CRVO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
55.23%28.29M
15.06%8.33M
49.07%8.04M
120.90%6.62M
104.35%5.3M
133.30%18.23M
191.92%7.24M
101.72%5.4M
143.31%3M
81.93%2.59M
Selling and administrative expenses
14.37%10.48M
8.37%2.51M
5.22%2.33M
30.01%3.27M
11.97%2.38M
40.61%9.17M
9.48%2.32M
-8.27%2.21M
153.05%2.51M
112.60%2.13M
-General and administrative expense
14.37%10.48M
8.37%2.51M
5.22%2.33M
30.01%3.27M
11.97%2.38M
40.61%9.17M
9.48%2.32M
-8.27%2.21M
153.05%2.51M
112.60%2.13M
Research and development costs
16.06%21.82M
-17.73%5.83M
17.86%6.04M
35.42%5.11M
71.90%4.84M
122.77%18.8M
148.19%7.09M
186.08%5.13M
92.63%3.77M
53.51%2.81M
Other operating expenses
58.86%-4.01M
99.60%-8.73K
83.37%-322.57K
46.56%-1.76M
18.31%-1.92M
-36.29%-9.74M
13.19%-2.16M
-27.07%-1.94M
-91.23%-3.29M
-66.72%-2.35M
Operating profit
-55.23%-28.29M
-15.06%-8.33M
-49.07%-8.04M
-120.90%-6.62M
-104.35%-5.3M
-133.30%-18.23M
-191.92%-7.24M
-101.72%-5.4M
-143.31%-3M
-81.93%-2.59M
Net non-operating interest income expense
-31.00%1.34M
-54.73%240.94K
-50.67%318.79K
-45.74%368.13K
407.22%408.99K
782.94%1.94M
348.52%532.18K
1,255.60%646.17K
3,731.48%678.44K
127.75%80.63K
Non-operating interest income
-31.00%1.34M
-54.73%240.94K
-50.67%318.79K
-45.74%368.13K
407.22%408.99K
782.94%1.94M
348.52%532.18K
1,255.60%646.17K
3,731.48%678.44K
127.75%80.63K
Other net income (expense)
-740.26%-8.33K
20.73%3.29K
64.33%-1.23K
-4,052.23%-10.26K
-350.00%-135
-100.02%-991
554.33%2.73K
-100.07%-3.44K
99.88%-247
-100.00%-30
Other non- operating income (expenses)
-740.26%-8.33K
20.73%3.29K
64.33%-1.23K
-4,052.23%-10.26K
-350.00%-135
-100.02%-991
554.33%2.73K
-100.07%-3.44K
99.88%-247
-100.00%-30
Income before tax
-65.53%-26.97M
-20.60%-8.09M
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
Income tax
Net income
-65.53%-26.97M
-20.60%-8.09M
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
Net income continuous Operations
-65.53%-26.97M
-20.60%-8.09M
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
Minority interest income
Net income attributable to the parent company
-65.53%-26.97M
-20.60%-8.09M
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-65.53%-26.97M
-20.60%-8.09M
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
Basic earnings per share
-47.52%-2.98
-10.00%-0.88
-52.73%-0.84
-159.26%-0.7
-36.59%-0.56
-146.34%-2.02
-92.16%-0.8
-184.62%-0.55
90.18%-0.27
60.19%-0.41
Diluted earnings per share
-47.52%-2.98
-10.00%-0.88
-52.73%-0.84
-159.26%-0.7
-36.59%-0.56
-146.34%-2.02
-92.16%-0.8
21.43%-0.55
90.18%-0.27
60.19%-0.41
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 55.23%28.29M15.06%8.33M49.07%8.04M120.90%6.62M104.35%5.3M133.30%18.23M191.92%7.24M101.72%5.4M143.31%3M81.93%2.59M
Selling and administrative expenses 14.37%10.48M8.37%2.51M5.22%2.33M30.01%3.27M11.97%2.38M40.61%9.17M9.48%2.32M-8.27%2.21M153.05%2.51M112.60%2.13M
-General and administrative expense 14.37%10.48M8.37%2.51M5.22%2.33M30.01%3.27M11.97%2.38M40.61%9.17M9.48%2.32M-8.27%2.21M153.05%2.51M112.60%2.13M
Research and development costs 16.06%21.82M-17.73%5.83M17.86%6.04M35.42%5.11M71.90%4.84M122.77%18.8M148.19%7.09M186.08%5.13M92.63%3.77M53.51%2.81M
Other operating expenses 58.86%-4.01M99.60%-8.73K83.37%-322.57K46.56%-1.76M18.31%-1.92M-36.29%-9.74M13.19%-2.16M-27.07%-1.94M-91.23%-3.29M-66.72%-2.35M
Operating profit -55.23%-28.29M-15.06%-8.33M-49.07%-8.04M-120.90%-6.62M-104.35%-5.3M-133.30%-18.23M-191.92%-7.24M-101.72%-5.4M-143.31%-3M-81.93%-2.59M
Net non-operating interest income expense -31.00%1.34M-54.73%240.94K-50.67%318.79K-45.74%368.13K407.22%408.99K782.94%1.94M348.52%532.18K1,255.60%646.17K3,731.48%678.44K127.75%80.63K
Non-operating interest income -31.00%1.34M-54.73%240.94K-50.67%318.79K-45.74%368.13K407.22%408.99K782.94%1.94M348.52%532.18K1,255.60%646.17K3,731.48%678.44K127.75%80.63K
Other net income (expense) -740.26%-8.33K20.73%3.29K64.33%-1.23K-4,052.23%-10.26K-350.00%-135-100.02%-991554.33%2.73K-100.07%-3.44K99.88%-247-100.00%-30
Other non- operating income (expenses) -740.26%-8.33K20.73%3.29K64.33%-1.23K-4,052.23%-10.26K-350.00%-135-100.02%-991554.33%2.73K-100.07%-3.44K99.88%-247-100.00%-30
Income before tax -65.53%-26.97M-20.60%-8.09M-62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M
Income tax
Net income -65.53%-26.97M-20.60%-8.09M-62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M
Net income continuous Operations -65.53%-26.97M-20.60%-8.09M-62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M
Minority interest income
Net income attributable to the parent company -65.53%-26.97M-20.60%-8.09M-62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -65.53%-26.97M-20.60%-8.09M-62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M
Basic earnings per share -47.52%-2.98-10.00%-0.88-52.73%-0.84-159.26%-0.7-36.59%-0.56-146.34%-2.02-92.16%-0.8-184.62%-0.5590.18%-0.2760.19%-0.41
Diluted earnings per share -47.52%-2.98-10.00%-0.88-52.73%-0.84-159.26%-0.7-36.59%-0.56-146.34%-2.02-92.16%-0.821.43%-0.5590.18%-0.2760.19%-0.41
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -